Saba Capital Management »

Conduit Pharmaceuticals shares owned by Saba Capital Management

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDTTW) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $57k 765k 0.07
2023-09-30 $34k 765k 0.05

More positions owned by Saba Capital Management

Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Adams Express Company (ADX)
ClearBridge Energy MLP Fund (EMO)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Clearbridge Mlp And Mids (CEM)
Hldgs Put Option (UAL)
Mainstay Cbre Global (MEGI)
Nuveen Nj Div Advantage Mun (NXJ)
Blackrock Calif Mun Income T Sh Ben Int (BFZ)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Charter Communications Inc N Cl A Put Option (CHTR)

View all positions for Saba Capital Management

Top funds holding Conduit Pharmaceuticals

Highbridge Capital Management
Polar Securities
Saba Capital Management
MMCAP International Inc. SPC
Exos TFP Holdings
Walleye Trading Advisors
D. E. Shaw & Co
Walleye Trading
Wolverine Asset Management
CNH Partners
Cowen And Company
Whitebox Advisors
Rivernorth Capital Management
Context Capital Management
Kim

View all funds holding Conduit Pharmaceuticals